Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseGlobe Newswire • about 1 month ago
CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Share to Feed
Palumbo Wealth Management LLC bought a new stake in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and...
Organogenesis Holdings Inc. (NASDAQ:ORGO Free Report) Investment analysts at Cantor Fitzgerald reduced their FY2024 earnings estimates for Organogenesis in a research report issued...
Swiss National Bank bought a new position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO Free Report) during the 3rd quarter, according to its most recent 13F filing with the...
Related Stocks: NAS:ORGO...
CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Q4 2023 Earnings Preview...
This is a Bullish indicator signaling ORGO's price could rise from here. Traders may explore going long the stock or buying call options...
This indicator may be signaling that ORGO's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This indicator may be signaling that ORGO's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...